Hospital Sant Joan de Deu -ko ikertzaileekin lankidetzan egindako argitalpenak (91)

2024

  1. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

  2. Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force

    Allergy: European Journal of Allergy and Clinical Immunology

2023

  1. Creation of a Pediatric Hospital Medicine Subspecialty in Spain

    Hospital Pediatrics

  2. Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: New splicing events

    Journal of Medical Genetics, Vol. 60, Núm. 6, pp. 615-619

  3. Increase in Incidence Rates and Risk Factors for Multidrug Resistant Bacteria in Septic Children: A Nationwide Spanish Cohort Study (2013–2019)

    Antibiotics, Vol. 12, Núm. 11

  4. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research

  5. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

  6. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    World Allergy Organization Journal, Vol. 16, Núm. 3

  7. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33

  8. “Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”

    Human Immunology, Vol. 84, Núm. 4, pp. 290-295

2022

  1. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

    Journal of Clinical Immunology, Vol. 42, Núm. 3, pp. 500-511

  2. Device Exposure and Patient Risk Factors’ Impact on the Healthcare-Associated Infection Rates in PICUs

    Children, Vol. 9, Núm. 11

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

    Schizophrenia, Vol. 8, Núm. 1

  5. Managing food allergy: GA2LEN guideline 2022

    World Allergy Organization Journal, Vol. 15, Núm. 9

  6. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  7. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018

    Emerging Infectious Diseases, Vol. 28, Núm. 5, pp. 967-976

  8. Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 3, pp. 372-381

2021

  1. Actividad cerebral en jóvenes infectados por el virus de la inmunodeficiencia humana por transmisión vertical: estudio piloto de resonancia magnética funcional

    Revista de neurologia, Vol. 72, Núm. 10, pp. 343-351

  2. Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: Study protocol for a randomised controlled trial (OPTIM-PTL Study)

    BMJ Open, Vol. 11, Núm. 9